Art. 3 Regulation (EU) 2016/161

Definitions

In forcesince 1 Jan 2022cited 5×
1.

For the purposes of this Regulation, the definitions in Article 1 of Directive 2001/83/EC shall apply.

2.

The following definitions shall apply:

(a)

‘unique identifier’ means the safety feature enabling the verification of the authenticity and the identification of an individual pack of a medicinal product;

(b)

‘anti-tampering device’ means the safety feature allowing the verification of whether the packaging of a medicinal product has been tampered with;

(c)

‘decommissioning of a unique identifier’ means the operation changing the active status of a unique identifier stored in the repositories system referred to in Article 31 of this Regulation to a status impeding any further successful verification of the authenticity of that unique identifier;

(d)

‘active unique identifier’ means a unique identifier which has not been decommissioned or which is no longer decommissioned, and which has not been identified as a ‘non-Union pack’ as referred to in Article 36, point (p);

(e)

‘active status’ means the status of an active unique identifier stored in the repositories system referred to in Article 31;

(f)

‘healthcare institution’ means a hospital, in- or outpatient clinic or health centre.

  • Opinion of Advocate General Szpunar delivered on 13 January 2022. Novartis Pharma GmbH v Abacus Medicine A/S.Decision

    By its fourth question, the referring court in Case C‑147/20 asks whether Article 5(3) of Delegated Regulation 2016/161 must be interpreted as meaning that the barcode containing the unique identifier, referred to in Article 3(2)(a) of …

    13 Jan 2022 · 62020CC0147

  • Judgment of the Court (Fifth Chamber) of 17 November 2022. Merck Sharp & Dohme BV and Others v Abacus Medicine A/S and Others.Decision

    Under Article 3(2) of Delegated Regulation 2016/161: ‘The following definitions shall apply: “unique identifier” means the safety feature enabling the verification of the authenticity and the identification of an individual pack of a …

    17 Nov 2022 · 62020CJ0224

  • Regulation (EU) 2022/315Lawamends

  • Judgment of the Court (Fifth Chamber) of 17 November 2022. Bayer Intellectual Property GmbH v kohlpharma GmbH.Decision

    Under Article 3(2) of Delegated Regulation 2016/161: ‘The following definitions shall apply: “unique identifier” means the safety feature enabling the verification of the authenticity and the identification of an individual pack of a …

    17 Nov 2022 · 62020CJ0204

  • Judgment of the Court (Fifth Chamber) of 17 November 2022. Novartis Pharma GmbH v Abacus Medicine A/S.Decisioninterprets

    Under Article 3(2) of Delegated Regulation 2016/161: ‘The following definitions shall apply: “unique identifier” means the safety feature enabling the verification of the authenticity and the identification of an individual pack of a …

    17 Nov 2022 · 62020CJ0147